What You Need to Know
Why You Should Get Tested
Recommended Resources

The Treatment Decision

The decision to get treatment for hep C is one of the most significant ones you will ever make. Use this tool to prepare a list of questions and concerns you may have and to evaluate the benefits of treatment.

Use the table below to indicate which of these benefits are most important to you:

Benefits of treatment Not
important
to me
Somewhat
important
to me
Very
important
to me
Most
important
to me
Getting rid of the virus
Staying strong
Avoiding further liver damage
Getting on with my life
Feeling better
Acting for my long-term health
Possibly reversing liver damage
Meeting this challenge
Taking back control
Best treatments now available
Putting my hep C behind me
Earlier treatment may mean better results
Continue

Use the table below to indicate which of these possible concerns are most important to you:

My main concerns
about treatment
Not
important
to me
Somewhat
important
to me
Very
important
to me
Most
important
to me
Self-injection/needles
Side effects
Obtaining/storing/managing medication
Treatment not working
Not being able to finish
Cost
Need for support
Questions during treatment
Impact on my life
Not a good time for me to start
Get Questions

Print this list

Questions

This list is based on your responses to potential benefits and concerns related to hep C treatment. It provides some questions you may want to ask your healthcare provider.

Remember, this is not meant to be a complete list. The decision to treat hep C is an important one and you should get answers to all your questions.

Facts

  • You're not alone: an estimated 3.9 million Americans have been infected with HCV.
  • 80% of people with hep C have no signs or symptoms of the disease. In fact, many people experience no symptoms that they are aware of until significant liver damage has occurred.
  • 70% of people who have chronic hep C infection go on to have chronic liver disease.
  • Combination therapy using pegylated interferon and ribavirin can get rid of the virus in up to 5 out of 10 persons with genotype 1 and in up to 8 out of 10 persons with genotype 2 and 3.
  • Patients treated earlier may respond better to hep C treatment.

Print this list